Scribe Therapeutics Inc Common Stock

Scribe Therapeutics Inc Common Stock

Price & Volume

Stats

See more
52W Range
$15-$39.60
Market Cap
$502.2M
Shares Short
778,191

Financials

See more
Revenue (12 Mos)
$33.3M
Revenue Growth (YoY)
-60.8%
Gross Profit (12 Mos)
-$17.7M
Diluted EPS
-$1.74

About

CEO
Dr. Benjamin L. Oakes Ph.D.
CFO
Mr. David L. Parrot M.B.A.
Address
1150 Marina Village Pkwy, Alameda, CA, United States, 94501
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
82